10X Genomics Inc (TXG) Stock Price, Quote & News

Company Profile

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and singl...

Industry: Health Information Services

Sector: Healthcare

Phone: 925 401 7300

Website: www.10xgenomics.com

Address:

6230 Stoneridge Mall Road, Pleasanton, United States

BudskieMcgee Apr. 10 at 2:57 AM

$TXG shorts let this go. All about fundamentals now. Big reveal coming on 4.18. This thing is set up to 🌖!!!!

0 · Reply

Bates333 Apr. 7 at 6:01 PM

$TXG @Professor thoughts?

0 · Reply

OfficialStocktwitsUser Apr. 3 at 3:09 AM

$TXG RSI: 64.65, MACD: 0.3931 Vol: 1.51, MA20: 19.72, MA50: 20.04 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Apr. 1 at 6:01 PM

$TXG Share Price: $22.72 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $5.61 – $6.93 Target Zone: $10.24 – $12.51 Potential Upside: 72% ROI Time to Expiration: 232 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

BudskieMcgee Apr. 1 at 5:23 PM

$TXG Big short squeeze coming! LFG!

0 · Reply

RunnerSignals Mar. 31 at 8:43 PM

$AMZN $TXG $RKLB $CDE $EAT Top Stock Upgrades today in the Buzz https://stocksrunner.com/news/2026-03-31-top-stock-upgrades-today-in-the-buzz

0 · Reply

Bates333 Mar. 31 at 7:58 PM

$TXG beautiful

0 · Reply

TalkMarkets Mar. 23 at 6:02 PM

#CathieWood Makes Just 3 Stock Buys Last Week — Here’s What She Chose $FIG $ARCT $TXG $CRCL $TER https://talkmarkets.com/article/d20a6bab-2765-4e02-b99e-4a9635d42dba

0 · Reply

mkultra Mar. 23 at 3:10 PM

$TXG toadaso🚀🚀🚀

0 · Reply

Bates333 Mar. 20 at 8:03 PM

$TXG nice relative out performer today

0 · Reply

10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout

Mar 25, 2026, 7:00 AM EDT - 16 days ago

Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

Mar 17, 2026, 8:00 AM EDT - 24 days ago

PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

Feb 19, 2026, 4:05 PM EST - 7 weeks ago

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Feb 12, 2026, 4:05 PM EST - 2 months ago

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026

Feb 4, 2026, 9:00 AM EST - 2 months ago

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Jan 22, 2026, 4:05 PM EST - 2 months ago

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Jan 12, 2026, 9:11 AM EST - 3 months ago

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Jan 12, 2026, 9:10 AM EST - 3 months ago

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Jan 12, 2026, 9:00 AM EST - 3 months ago

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Jan 11, 2026, 12:00 PM EST - 3 months ago

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Jan 7, 2026, 7:05 AM EST - 3 months ago

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CDNA

Dec 29, 2025, 4:05 PM EST - 3 months ago

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 9:00 AM EST - 5 months ago

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium

Nov 11, 2025, 4:05 PM EST - 5 months ago

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

Nov 6, 2025, 4:05 PM EST - 5 months ago

10x Genomics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 9:00 AM EDT - 5 months ago

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

Oct 20, 2025, 12:30 PM EDT - 6 months ago

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

Oct 9, 2025, 4:05 PM EDT - 6 months ago

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 9, 2025, 8:00 AM EDT - 6 months ago

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

Sep 9, 2025, 9:00 AM EDT - 7 months ago

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Aug 27, 2025, 4:05 PM EDT - 8 months ago

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 9:00 AM EDT - 8 months ago

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

Aug 7, 2025, 4:05 PM EDT - 8 months ago

10x Genomics Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:04 PM EDT - 8 months ago

10x Genomics to Acquire Scale Biosciences

Jul 17, 2025, 9:00 AM EDT - 9 months ago

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

Jul 10, 2025, 4:05 PM EDT - 9 months ago

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

May 14, 2025, 4:05 PM EDT - 11 months ago

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

May 8, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

Mar 3, 2025, 4:05 PM EST - 1 year ago

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

Feb 23, 2025, 11:30 AM EST - 1 year ago

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

Feb 18, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

Feb 13, 2025, 3:10 PM EST - 1 year ago

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties

Feb 12, 2025, 7:19 PM EST - 1 year ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN PACB

Feb 12, 2025, 4:05 PM EST - 1 year ago

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

Feb 6, 2025, 8:30 AM EST - 1 year ago

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Feb 4, 2025, 8:59 AM EST - 1 year ago

Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products

Jan 31, 2025, 6:34 AM EST - 1 year ago

Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE

Jan 28, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Jan 2, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:05 PM EST - 1 year ago

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

BRKR

Nov 7, 2024, 4:05 PM EST - 1 year ago

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference

Oct 31, 2024, 8:00 AM EDT - 1 year ago

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative

Oct 30, 2024, 2:41 PM EDT - 1 year ago

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results

Oct 29, 2024, 4:05 PM EDT - 1 year ago

10x Genomics Reports Third Quarter 2024 Financial Results

Oct 15, 2024, 4:05 PM EDT - 1 year ago

10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches

Oct 9, 2024, 4:05 PM EDT - 1 year ago

10x Genomics Announces Preliminary Select Third Quarter 2024 Results

Oct 1, 2024, 4:05 PM EDT - 1 year ago

10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting

BudskieMcgee Apr. 10 at 2:57 AM

$TXG shorts let this go. All about fundamentals now. Big reveal coming on 4.18. This thing is set up to 🌖!!!!

0 · Reply

Bates333 Apr. 7 at 6:01 PM

$TXG @Professor thoughts?

0 · Reply

OfficialStocktwitsUser Apr. 3 at 3:09 AM

0 · Reply

SuperGreenToday Apr. 1 at 6:01 PM

0 · Reply

BudskieMcgee Apr. 1 at 5:23 PM

$TXG Big short squeeze coming! LFG!

0 · Reply

RunnerSignals Mar. 31 at 8:43 PM

$AMZN $TXG $RKLB $CDE $EAT Top Stock Upgrades today in the Buzz https://stocksrunner.com/news/2026-03-31-top-stock-upgrades-today-in-the-buzz

0 · Reply

Bates333 Mar. 31 at 7:58 PM

$TXG beautiful

0 · Reply

TalkMarkets Mar. 23 at 6:02 PM

#CathieWood Makes Just 3 Stock Buys Last Week — Here’s What She Chose $FIG $ARCT $TXG $CRCL $TER https://talkmarkets.com/article/d20a6bab-2765-4e02-b99e-4a9635d42dba

0 · Reply

mkultra Mar. 23 at 3:10 PM

$TXG toadaso🚀🚀🚀

0 · Reply

Bates333 Mar. 20 at 8:03 PM

$TXG nice relative out performer today

0 · Reply

BudskieMcgee Mar. 20 at 2:42 PM

$TXG this thing is going to the moon. Industry changing announcement on April 18! 👀

1 · Reply

mkultra Mar. 18 at 11:23 PM

$TXG NIH funding turned back on. TXG is gonna absolutely rip this year

0 · Reply

topstockalerts Mar. 17 at 5:18 PM

Shares of Bruker Corporation and 10x Genomics fell after Satya Nadella highlighted GigaTIME, an AI model developed by Microsoft, Providence Health, and the University of Washington that can predict multiplex immunofluorescence results from H&E pathology slides. The selloff reflected concerns that AI could reduce demand for spatial proteomics, but Wolfe Research argued the reaction was overdone, noting these tools are not yet widely used in clinical settings and the underlying study was published months ago in Cell. GigaTIME uses multimodal AI trained on 40 million cells and tested across 14,000+ patients, analyzing 21 protein markers including PD-L1. However, Wolfe said this marker set is relatively limited compared to traditional methods, suggesting the technology remains early-stage rather than a near-term replacement. $BRKR $TXG

2 · Reply

medguy Mar. 17 at 5:44 AM

Looking for bounce $TXG $VIA

0 · Reply

financials_please Mar. 16 at 7:35 PM

$TXG based on past history, Cathy dumping is a glowing endorsement here 😂

1 · Reply

Guadangia Mar. 16 at 6:53 PM

$TXG I bought a few from Cathie's today. AFAIK Ark has around 11 million shares, and she sold how many, 750k, 1 million? Still has 10M shares... And anyways that's not the important thing. The chart speaks itself. I thought the right shoulder would take a few more sessions to develop (green box), but it seems they are in a rush. Very optimistic on this one (targets in blue box).

0 · Reply

Eddyg987 Mar. 16 at 3:48 PM

$TXG cathy has decided to dump her shares

4 · Reply

buyitall888 Mar. 16 at 2:45 PM

$TXG omg why's it tanking huge rn

0 · Reply

dark_gamma Mar. 11 at 10:37 PM

$USO OPTIONS LEVELS UPDATE Current Date: 2026-03-11 Key Levels to Watch: ✅ Call Wall: $110.00 - A significant resistance level ❌ Put Wall: $108.00 - A crucial support level ⚡ Gamma Flip: $109.39 - A level of increased sensitivity to price movements Whale Activity: ~ Dark Gamma: $106.40 - A whale's position indicating potential market direction • Whale 1: $105.92 • Whale 2: $TXG • Whale 3: $106.14 • Whale 4: $TXG • Whale 5: $105.70 - Various whale positions revealing market sentiment Volatility Ranges: ⬆ Upper: 1σ $116.12 | 2σ $124.19 - Indicative of potential price increases ⬇ Lower: 1σ $99.98 | 2σ $91.91 - Indicative of potential price decreases Daily Level Updates: Check back regularly for updated market information. Disclaimer: This information is for educational purposes only and should not be considered as investment advice.

0 · Reply

OfficialStocktwitsUser Mar. 4 at 2:45 AM

$TXG RSI: 68.92, MACD: 0.7335 Vol: 1.71, MA20: 19.60, MA50: 19.46 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

IN0V8 Mar. 3 at 6:01 PM

$TXG 3/2 Stifel raises target price to $25 from $20

1 · Reply

erevnon Mar. 2 at 3:54 PM

Stifel maintains 10x Genomics $TXG at Buy and raises the price target from $20 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Market Cap	2.79B
Revenue (ttm)	642.82M
Net Income (ttm)	-43.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.77%
Debt to Equity Ratio	0.00

Volume	1,181,266
Avg Vol	2,535,904
Day's Range	N/A - N/A
Shares Out	127.75M
Stochastic %K	86%
Beta	2.17
Analysts	Sell
Price Target	$20.14